Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aptevo Therapeutics (APVO) Assets (2016 - 2023)

Historic Assets for Aptevo Therapeutics (APVO) over the last 9 years, with Q3 2023 value amounting to $27.1 million.

  • Aptevo Therapeutics' Assets fell 1440.61% to $27.1 million in Q3 2023 from the same period last year, while for Sep 2023 it was $27.1 million, marking a year-over-year decrease of 1440.61%. This contributed to the annual value of $34.2 million for FY2022, which is 3955.05% down from last year.
  • Per Aptevo Therapeutics' latest filing, its Assets stood at $27.1 million for Q3 2023, which was down 1440.61% from $28.9 million recorded in Q2 2023.
  • In the past 5 years, Aptevo Therapeutics' Assets ranged from a high of $80.8 million in Q1 2019 and a low of $18.5 million during Q2 2020
  • Moreover, its 5-year median value for Assets was $45.2 million (2022), whereas its average is $47.2 million.
  • As far as peak fluctuations go, Aptevo Therapeutics' Assets tumbled by 7200.99% in 2020, and later surged by 28615.81% in 2021.
  • Over the past 5 years, Aptevo Therapeutics' Assets (Quarter) stood at $53.4 million in 2019, then grew by 0.26% to $53.5 million in 2020, then rose by 5.7% to $56.6 million in 2021, then plummeted by 39.55% to $34.2 million in 2022, then dropped by 20.71% to $27.1 million in 2023.
  • Its last three reported values are $27.1 million in Q3 2023, $28.9 million for Q2 2023, and $35.0 million during Q1 2023.